Stellate Ganglion Block

Launched by UNIVERSITY OF MINNESOTA · Feb 14, 2024

Keywords

ClinConnect Summary

This clinical trial is studying whether a specific type of pain relief called a stellate ganglion block can help reduce the risk of a heart condition known as atrial fibrillation after certain surgeries. The surgeries involved are esophagectomy (removal of part of the esophagus), pneumonectomy (removal of a lung), and lobectomy (removal of a lobe of the lung). The trial will use an ultrasound to guide the procedure and will involve a medication called bupivacaine to help with pain management.

To participate in this study, individuals must be between 18 and 85 years old and scheduled for one of the surgeries mentioned. However, some people may not be eligible if they have specific conditions that prevent them from receiving this type of pain relief, or if they are pregnant. The study is not yet recruiting participants, but once it starts, those who join can expect close monitoring and care related to both their surgery and the block procedure. This trial aims to improve outcomes for patients undergoing these significant surgeries.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients undergoing esophagectomy, pneumonectomy, or lobectomy aged 18-85.
• Exclusion Criteria:
• • Patients who have an exclusion to regional anesthesia.
• • Patients who have exclusion to stellate blockade.
• • Patients who are pregnant assessed via self-report or pregnancy test if they have taken one